BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

The Scientist Awards Seahorse Bioscience XF96 Analyzer a Top Ten Innovation for 2009


12/30/2009 9:51:55 AM

NORTH BILLERICA, Mass., Dec. 29 /PRNewswire/ -- Seahorse Bioscience, Inc., leader in the design and development of instruments for measuring cellular bioenergetics, announced that TheScientist magazine cited their XF96 Extracellular Flux Analyzer as a 2009 Top Ten Innovation.

"The XF Analyzers are revealing unexpected information about cellular respiration of cells that was not possible to attain before," noted John Lemasters, Director of the Center for Cell Death, Injury and Regeneration at the Medical University of South Carolina. "Insights from these findings are suggesting new strategies to rescue cells and tissues from irreversible toxic and ischemic injury."

"The XF Analyzer allows a scientist to see cancer cell metabolism in real time," stated Dr. Min Wu, Manager of Assay Development at Seahorse and author of several important cancer papers. "Studies utilizing the XF are revealing the metabolic dependencies of cancer cells on sugar and potential therapies. Scientists can determine whether a cancer is addicted to glucose (sugar) or glutamine, and establish which pathway to target for intervention."

One of TheScientist's judge's Dr. H. Steven Wiley, summed up the XF Analyzer's significance stating: "I want one!'

CONTACT: Cynthia Egan of Seahorse Bioscience, Inc., +1-978-671-1610

Web site: http://www.seahorsebio.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->